MaxHealth Biotechnology

Company Deals

MaxHealth Biotechnology Completes Series B+ Financing Round

Fineline Cube Dec 7, 2022

Chengdu-based vaccine developer MaxHealth Biotechnology LLC announced the completion of a Series B+ financing round...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod